论文部分内容阅读
激光、血卟啉衍生物(简称 HPD)光敏诊疗肺癌,近年来取得了可喜的成效。我院对经组织病理学证实的66例气管、支气管腔内瘤体进行了治疗,有效率达93.93%(62/66)。用 J-84型影象增强仪对58例患者进行了荧光检测,符合率为93.10%。报道如下:
Lasers and hematoporphyrin derivatives (abbreviated as HPD) have been used in the diagnosis and treatment of lung cancer in recent years. They have achieved encouraging results in recent years. In our hospital, 66 cases of tracheal and endobronchial tumors confirmed by histopathology were treated with an effective rate of 93.93% (62/66). Fifty-eight patients were examined for fluorescence using the J-84 Image Enhancer and the compliance rate was 93.10%. The report is as follows: